Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1765
  • Home
  • Print this page
  • Email this page
PERSPECTIVE
Year : 2020  |  Volume : 68  |  Issue : 13  |  Page : 108-114

Operational guidelines for ROP in India: A summary


1 Associate Professor, Health Policy and Management, India ROP Partners Implementation Consortium, Indian Institute of Public Health, Hyderabad, India
2 Associate Professor, Health Policy and Management, India ROP Partners Implementation Consortium, Indian Institute of Public Health, Hyderabad, India; International Centre for Eye Health, Department of Clinical Research, London School Hygiene & Tropical Medicine, London, UK
3 International Centre for Eye Health, Department of Clinical Research, London School Hygiene & Tropical Medicine, London, UK

Correspondence Address:
Dr. Rajan Shukla
Indian Institute of Public Health Hyderabad, Plot # 1, A N V Arcade, Amar Co-operative Society, Kavuri Hills, Madhapur, Hyderabad - 500 033, Telangana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_1827_19

Rights and Permissions

Retinopathy of Prematurity (ROP) is a potentially blinding disease of the eye that can affect infants born four or more weeks preterm and have received intensive neonatal care. ROP is a dynamic, time-bound disease that is not present at birth. Preventing visual loss from ROP in India requires scaling up services for screening and treatment for ROP to match the exponential growth in neonatal intensive care in India and other low- and middle-income countries. Operational guidelines for prevention of visual loss from ROP will facilitate rapid scale up of services, by identifying key players and their roles and responsibility in the Indian context. The guidelines recommend broad eligibility criteria for screening (gestational age ≤34 weeks, birth weight ≤2000 gms) as the special newborn care unit (SNCU) have varying quality of neonatal care. Treatment is based on the early treatment for retinopathy of prematurity (ET-ROP) study treatment criteria. The screening criteria could be revisited when more contextual evidence on the risk of ROP is available in India.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed967    
    Printed4    
    Emailed0    
    PDF Downloaded236    
    Comments [Add]    

Recommend this journal